University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

Greater utility of molecular subtype rather than epithelial-to-mesenchymal transition (EMT) markers for prognosis in high-risk non-muscle-invasive (HGT1) bladder cancer

Simple item page
dc.contributor.authorOttley, Edward C.
dc.contributor.authorPell, Robert
dc.contributor.authorBrazier, Benedict
dc.contributor.authorHollidge, Julianne
dc.contributor.authorKartsonaki, Christiana
dc.contributor.authorBrowning, Lisa
dc.contributor.authorO'Neill, Eric
dc.contributor.authorKiltie, Anne E.
dc.contributor.institutionUniversity of Aberdeen.Rowett Instituteen
dc.date.accessioned2021-11-01T17:39:01Z
dc.date.available2021-11-01T17:39:01Z
dc.date.issued2020-10-01
dc.descriptionFunding Information: ECO and AEK were funded by CRUK programme grant C5255/A23755. We would like to thank Marcus Green for cutting the sections and giving advice on optimisation of antibodies and to Dr Jong‐Wei Hsu for advice on antibody selection. LB was supported by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC). The views expressed are those of the authors and not necessarily those of the National Health Service (NHS), the NIHR or the Department of Health. LB is part of the PathLAKE digital pathology consortium. These new Centres are supported by a £50m investment from the Data to Early Diagnosis and Precision Medicine strand of the UK government's Industrial Strategy Challenge Fund, managed and delivered by UK Research and Innovation (UKRI).en
dc.description.statusPeer revieweden
dc.format.extent14
dc.format.extent3887694
dc.identifier195022562
dc.identifierdb2bb43e-7a46-4e08-b57c-5beadf310412
dc.identifier85085096147
dc.identifier32374509
dc.identifier.citationOttley, E C, Pell, R, Brazier, B, Hollidge, J, Kartsonaki, C, Browning, L, O'Neill, E & Kiltie, A E 2020, 'Greater utility of molecular subtype rather than epithelial-to-mesenchymal transition (EMT) markers for prognosis in high-risk non-muscle-invasive (HGT1) bladder cancer', Journal of Pathology: Clinical Research, vol. 6, no. 4, pp. 238-251. https://doi.org/10.1002/cjp2.167en
dc.identifier.doi10.1002/cjp2.167
dc.identifier.iss4en
dc.identifier.issn2056-4538
dc.identifier.otherORCID: /0000-0001-7208-2912/work/102537010
dc.identifier.urihttps://hdl.handle.net/2164/17424
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85085096147&partnerID=8YFLogxKen
dc.identifier.vol6en
dc.language.isoeng
dc.relation.ispartofJournal of Pathology: Clinical Researchen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectbiomarkersen
dc.subjectbladder canceren
dc.subjectepithelial-to-mesenchymal transitionen
dc.subjectimmunohistochemistryen
dc.subjectmolecular subtypesen
dc.subjectR Medicineen
dc.subjectPathology and Forensic Medicineen
dc.subjectCancer Research UKen
dc.subjectC5255/A23755en
dc.subjectNational Institute for Health Research (NIHR)en
dc.subject.lccRen
dc.titleGreater utility of molecular subtype rather than epithelial-to-mesenchymal transition (EMT) markers for prognosis in high-risk non-muscle-invasive (HGT1) bladder canceren
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Ottley_etal_JPCR_Greater_utility_of_VOR.pdf
Size:
3.71 MB
Format:
Adobe Portable Document Format
Download

Collections

All research

The Sir Duncan Rice Library

University of Aberdeen

Bedford Road

Aberdeen

AB24 3AA


Tel: +44 (0)1224 273330

Email: library@abdn.ac.uk

Share and keep up to date


FacebookTwitterWordpress